Raymond James Financial, Inc.

RJF · NYSE

Market closed$168.36$-1.34 (-0.79%)After hours $168.36 · 0.00%

Key statistics

Previous close$169.70
Open$166.33
Day high$170.79
Day low$166.20
52-week high$177.66
52-week low$138.82
Market cap32.81B
Volume729.86K
Average volume1.46M
P/E ratio15.33
Forward P/E11.89
EPS10.98
Dividend yield+1.26%

Market context

Why it moved

RJF edged lower ahead of its scheduled earnings report, as investors adopted a cautious stance amid broader market weakness driven by a chip sector selloff pulling U.S. equities lower, despite an analyst upgrade citing a strong Q3 outlook and growth in key wealth management segments.

What is happening

Recent company-specific developments and publisher coverage.

July 17, 2026Raymond James Financial closed modestly lower amid a broader risk-off session as escalating U.S.-Iran tensions and a deteriorating AI narrative weighed on equities. Analyst sentiment remains constructive heading into the company's upcoming earnings, with Barclays raising its price target to $192 (overweight), Citizens JMP lifting its target to $200 (market outperform), and a Seeking Alpha upgrade to Buy — all underpinned by Raymond James' strong fiscal Q2 beat ($2.83 EPS vs. $2.76 estimate) and 13.4% year-over-year revenue growth, with the company's 2026 Investor Day drawing additional investor interest.

-0.7896

July 17, 2026Raymond James Financial edged slightly lower amid a broadly mixed session for financial stocks, with the XLF sector ETF near 52-week highs. Investors are focused on an upcoming Seeking Alpha upgrade to Buy citing strong short- and long-term potential ahead of the next earnings report and 2026 Investor Day, while a wave of bullish analyst target hikes — including Barclays raising to $192 (Overweight) and Citizens JMP to $200 — reflects optimism around wealth management momentum and margin expansion. The backdrop of blowout Q2 earnings from major Wall Street banks, with capital markets activity and M&A advisory at multi-year highs, is seen as a constructive read-through for Raymond James.

-0.3523

July 15, 2026Raymond James Financial closed up roughly 1.71%, lifted by a powerful tailwind from Wall Street's blowout Q2 earnings season, with JPMorgan, Goldman Sachs, Bank of America, and Morgan Stanley all reporting surging investment banking fees and trading revenue that bolstered sentiment across capital markets firms. Analysts have grown more constructive on RJF, with Citizens JMP raising its price target to $200 and Barclays to $192, pushing the consensus target to $176.64, while the company's own April earnings beat—$2.83 EPS vs. $2.76 expected on 13.4% revenue growth—and today's quarterly dividend payment of $0.54/share reinforced the fundamental backdrop. The XLF financial sector ETF touched a 52-week high intraday, reflecting broad sector strength.

1.7141

July 14, 2026Raymond James Financial closed modestly higher as the broader financial sector rallied on blowout Q2 earnings from Wall Street giants including JPMorgan, Goldman Sachs, and Bank of America, with investment banking fees and trading revenues surging to multi-year highs. The constructive backdrop for capital markets — fueled by record IPO activity including SpaceX and robust M&A dealmaking — bodes well for Raymond James, which reported its own record Q2 revenues of $3.86 billion in April and has a strong investment banking pipeline heading into Q3. A $0.54 quarterly dividend is set to pay on July 15, and analyst price targets remain elevated, with Citizens JMP at $200 and Barclays at $192.

0.2695

July 14, 2026Raymond James Financial edged lower amid a broad market pullback driven by renewed U.S.-Iran military strikes that sent oil prices surging and rattled equity sentiment — with the S&P 500 closing down on the day. Despite the macro headwinds, the wealth management firm remains in focus ahead of a pivotal week for financial sector earnings, with major bank results due Tuesday that could reinforce the bullish capital markets backdrop that helped RJF post record Q2 revenues of $3.86 billion and beat EPS estimates. Analyst sentiment has grown more constructive post-earnings, with Citizens JMP raising its price target to $200 and Barclays to $192, while Morgan Stanley lifted its target to $174 — though the consensus remains Hold at an average target of $176.64, still above current levels.

-0.6781

July 10, 2026Raymond James Financial edged lower in regular trading and extended its decline in after-hours, as JPMorgan raised its price target to $175 and Morgan Stanley lifted its target to $174 (from $172) while maintaining an Equal-Weight rating. The analyst activity comes ahead of Q2 bank earnings season, with the broader financial sector trading near historically attractive valuations (~15.5x forward earnings) and Wall Street broadly bullish on capital markets momentum. RJF's recent Q1 beat — $2.83 EPS vs. $2.76 estimate, with 13.4% revenue growth — has drawn fresh valuation interest, with some analysts seeing the stock as modestly undervalued near current levels.

-0.3556

July 9, 2026Raymond James Financial rose roughly 2% as multiple analyst price target upgrades provided a tailwind against an otherwise choppy macro backdrop. Barclays raised its price target to $192 from $182 (maintaining Overweight), while Citizens lifted its target to $200 from $190, signaling growing conviction ahead of Q2 earnings season. The constructive analyst tone comes as the broader financial sector benefits from expectations of strong capital markets activity, robust M&A and IPO pipelines, and resilient loan growth — despite renewed geopolitical risk from U.S.-Iran tensions pushing oil prices higher and reigniting rate hike concerns.

2.0381

July 9, 2026Raymond James Financial closed modestly lower as a broad risk-off selloff swept through diversified financials after President Trump declared the Iran ceasefire 'over,' sending oil prices surging more than 5% and rattling capital markets-sensitive names. The decline came despite a fresh analyst catalyst: UBS raised its price target on Raymond James to $175 from $166 while maintaining a Neutral rating, and the firm's own Q2 earnings call highlighted record revenues of $3.86 billion, 13% year-over-year growth, and a robust investment banking pipeline. The XLF financial sector ETF also fell sharply, with peers like Lazard, Ameriprise, and Franklin Resources each dropping 2.5–3%+, underscoring the broad sector pressure from geopolitical uncertainty and rising rate-hike expectations.

-1.3425

ad-hoc-news.de · July 19, 2026Raymond James stock trades steady as advisory revenue supports earningsSeeking Alpha · July 16, 2026Raymond James: Turning Bullish After Earnings Preview And Investor Day (Upgrade) (RJF)TradingView · July 3, 2026Raymond James Financial holds 2026 Analyst & Investor Day, outlines growth, tech and capital prioritiesStock Titan · June 24, 2026Raymond James (NYSE: RJF) reports record $1.92T client assets and 35% AUM growthStock Titan · April 22, 2026Raymond James adds $23B in client assets as revenue hits record
Benzinga · July 10, 2026Morgan Stanley Maintains Equal-Weight on Raymond James Finl, Raises Price Target to $174
Mt Newswire · July 10, 2026JPMorgan Adjusts Price Target on Raymond James Financial to $175 From $168
Mt Newswire · July 10, 2026Morgan Stanley Adjusts Price Target on Raymond James Financial to $174 From $172
Mt Newswire · July 9, 2026Barclays Adjusts Price Target on Raymond James Financial to $192 From $182
Benzinga · July 9, 2026Barclays Maintains Overweight on Raymond James Finl, Raises Price Target to $192
Mt Newswire · July 9, 2026Citizens Adjusts Price Target on Raymond James Financial to $200 From $190
Benzinga · July 8, 2026UBS Maintains Neutral on Raymond James Finl, Raises Price Target to $175
Mt Newswire · July 8, 2026UBS Adjusts Price Target on Raymond James Financial to $175 From $166, Maintains Neutral Rating

Peers